← Back to Dashboard

ZIKV

Zika virus

8
Approved Drugs
0
Phase 3
0
Phase 2
64
Preclinical
72
Total Compounds

Antiviral Compounds

Acetylsalicylic acidZIKVCyclooxygenase inhibitor
Preclinical
Human COX
AmodiaquineZIKVMethyltransferase inhibitor
Preclinical
Human HNMT
AnisomycinZIKVDNA synthesis inhibitor
Preclinical
Human ribosome
AtovaquoneZIKVUnknown
Preclinical
Human DHODH
AzaribineZIKVInhibition of Viral Genome Replication
Preclinical
Viral RNA pol
AzauridineZIKVNucleoside analog
Preclinical
Viral RNA pol
AzithromycinZIKV
Preclinical
Human (multiple)
BerberineZIKVAMP-activated protein kinase (AMPK) activator
Preclinical
Unknown
Betulinic AcidZIKVUnknown
Preclinical
Unknown
BithionolZIKVUncoupler of oxidative phosphorylation
Preclinical
Unknown
BortezomibZIKVProteasome inhibitor (26S subunit)
Preclinical
Human proteasome
ChloroquineZIKVAntimalaria agent; chemo/radio sensitizer
Preclinical
Human (multiple)
ChlorpromazineZIKVInhibits assembly of clathrin-coated pits at the plasma membrane
Preclinical
Human (multiple)
ClofazimineZIKVNon-nucleoside RT inhibitor
Preclinical
Viral RNA pol
ClotrimazoleZIKVBlock Viral Entry (KCa3.1 antagonist)
Preclinical
Human cytochrome P450
CR-1-31-BZIKVPrevents mRNA translation
Preclinical
Human ATPase
Cucurbit[7]urilZIKVCompetitive binding of polyamines
Preclinical
Human polyamines
CyclosporineZIKVCalcineurin inhibitor; allows for inhibition of T cell activation
Preclinical
Human CYPs
DalbavancinZIKV
Preclinical
Unknown
DyphillinZIKVvacuolar ATPase inhibitors
Preclinical
Human vATPase
EfavirenzZIKVInhibition of viral RT
Approved (other)
JapanRussia
Viral RNA pol
EflornithineZIKVEnzyme-activated; irreversible inhibitor of ornithine decarboxylase
Preclinical
Human ODC
EmetineZIKV
Preclinical
Human ribosome
EmodinZIKV
Preclinical
Human (multiple)
EnoxacinZIKVDNA Topoisomerase II inhibitor
Preclinical
Human topoisomerase
Showing 1 to 25 of 72 results
Page 1 of 3